RETRACTED: Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2
Ming-feng Yang,
Sheng-yao Sun,
Hai-guang Lv,
Wei-qi Wang,
Han-xia Li,
Jing-yi Sun,
Zong-yong Zhang
Affiliations
Ming-feng Yang
Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai’an, Shandong, People’s Republic of China
Sheng-yao Sun
Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai’an, Shandong, People’s Republic of China
Hai-guang Lv
Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai’an, Shandong, People’s Republic of China
Wei-qi Wang
Shandong Provincial Hospital Affiliated to Shandong First Medical University, Ji’nan, Shandong, People’s Republic of China
Han-xia Li
Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai’an, Shandong, People’s Republic of China
Jing-yi Sun
Shandong Provincial Hospital Affiliated to Shandong First Medical University, Ji’nan, Shandong, People’s Republic of China
Zong-yong Zhang
Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai’an, Shandong, People’s Republic of China